ARTICLE | Company News
Raptor, Seattle Children's Research Institute deal
October 22, 2012 7:00 AM UTC
The institute granted Raptor exclusive, worldwide rights to IP related to cysteamine and related compounds for the potential treatment of fibrosis, including chronic kidney disease (CKD). Raptor is de...